Condition
Hepatobiliary Diseases
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
Trial Status
Not Yet Recruiting1
Recruiting1
Terminated1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07556835Not Yet Recruiting
Outcomes After Liver and Biliary Resection at a High-Volume Center
NCT07335042Recruiting
Prediction Model for MINS After Major Hepatobiliary Surgery
NCT01200082TerminatedPrimary
Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases
NCT05264688UnknownPrimary
The Function of PET Molecular Imaging Targeting Fibroblast Activation Protein in the Hepatobiliary Malignancies
Showing all 4 trials